Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Mol Genet Metab. 2011 Jul 12;104(3):383–389. doi: 10.1016/j.ymgme.2011.07.007

Figure 1.

Figure 1

Markov model analytic decision tree comparing two strategies: 1) newborn screening, and 2) no screening. The following models at the terminal end of each limb depict the possible stochastic processes of affected SCID identified early by screening (Markov model B), affected SCID identified after manifestation of symptoms (Markov model A), or unaffected non-SCID infants (Markov model C).